Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ioannou

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
Hepatology (Baltimore, Md.)|May 25, 2013
Chronic hepatitis B infection: a global disease requiring global strategiesGeorge N Ioannou
Gastroenterology|November 15, 2008
Implications of elevated serum alanine aminotransferase levels: think outside the liverGeorge N Ioannou
Annals of Internal Medicine|March 2, 2011
Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative surveyGeorge N Ioannou
Hepatology (Baltimore, Md.)|March 26, 2005
Percutaneous ablation for hepatocellular carcinomaGeorge N Ioannou
Gastroenterology|November 16, 2005
The natural history of NAFLD: impressively unimpressiveGeorge N Ioannou
The American Journal of Gastroenterology|January 14, 2010
Cholelithiasis, cholecystectomy, and liver diseaseGeorge N Ioannou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 23, 2016
Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinomaGeorge N Ioannou
Alimentary Pharmacology & Therapeutics|October 19, 2019
Editorial: hepatocellular carcinoma in the absence of cirrhosis-a nightmare without solutionGeorge N Ioannou
Gastroenterology|January 1, 2016
ReplyKristin Berry, George N Ioannou
Gastroenterology|May 30, 2015
Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United StatesKristin Berry, George N Ioannou
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
Hepatology (Baltimore, Md.)|May 25, 2013
Chronic hepatitis B infection: a global disease requiring global strategiesGeorge N Ioannou
Gastroenterology|November 15, 2008
Implications of elevated serum alanine aminotransferase levels: think outside the liverGeorge N Ioannou
Annals of Internal Medicine|March 2, 2011
Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative surveyGeorge N Ioannou
Hepatology (Baltimore, Md.)|March 26, 2005
Percutaneous ablation for hepatocellular carcinomaGeorge N Ioannou
Gastroenterology|November 16, 2005
The natural history of NAFLD: impressively unimpressiveGeorge N Ioannou
The American Journal of Gastroenterology|January 14, 2010
Cholelithiasis, cholecystectomy, and liver diseaseGeorge N Ioannou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 23, 2016
Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinomaGeorge N Ioannou
Alimentary Pharmacology & Therapeutics|October 19, 2019
Editorial: hepatocellular carcinoma in the absence of cirrhosis-a nightmare without solutionGeorge N Ioannou
Gastroenterology|January 1, 2016
ReplyKristin Berry, George N Ioannou
Gastroenterology|May 30, 2015
Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United StatesKristin Berry, George N Ioannou
Pageof 28